Bellwether Advisors, LLC Moderna, Inc. Transaction History

Bellwether Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$135.66 - $197.02 $2.27 Million - $3.29 Million	16,720 Added 16720.0%	16,820 $2.58 Million
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $1,171 - $1,765	-10 Reduced 9.09%	100 $14,000
Q4 2021 Jan 28, 2022	SELL	$225.82 - $368.51 $635,231 - $1.04 Million	-2,813 Reduced 96.24%	110 $27,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $626,423 - $1.37 Million	2,823 Added 2823.0%	2,923 $1.12 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $12,991 - $23,498	100 New	100 $23,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.